🇺🇸 FDA
Patent

US 9861606

Therapeutic for treating inflammatory lung disorders

granted A61KA61K31/138A61K31/277

Quick answer

US patent 9861606 (Therapeutic for treating inflammatory lung disorders) held by University College Cardiff Consultants Limited expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University College Cardiff Consultants Limited
Grant date
Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/138, A61K31/277, A61K45/06, A61K9/0075